NFE2L2 and colitis: It activates the NLRP3 inflammasome by reducing the enrichment of H3K27me3 in the Nrf2's promoter, resulting in elevating Nrf2 levels and subsequent promotion of NLRP3 inflammasome assembly, ultimately contributing to colitis progression [91].